SFX by Ex Libris Inc.

Title:	Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation
Source:	Nature [0028-0836] Riol Blanco, L yr:2014

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Chaturvedi, V. "CXCR3 blockade protects against Listeria monocytogenes infection-induced fetal wastage." The Journal of clinical investigation 125.4 (2015): 1713-1725.
description	2.	Van Etten, Richard S. "Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche." Blood 123.9 (2014): 1361-1371.
description	3.	Schmitt, J. "Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials." British journal of dermatology 170.2 (2013): 274-303.
description	4.	Jones, C.-H. G. "Fueling Immunity: Insights into Metabolism and Lymphocyte Function." Science 342.6155 (2013): 1242454-1242454.
description	5.	Nair, RP P. "Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappa B pathways." Nature genetics 41.2 (2009): 199-204.
description	6.	Liu, Y. "Psoriasis: genetic associations and immune system changes." Genes and immunity 8.1 (2007): 1-12.
description	7.	Liu, Jian-Jun J. "Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21." Nature genetics 41.2 (2009): 205-10.
description	8.	NJ, M. "Metabolic Regulation of T Lymphocytes." Annual review of immunology 31.1: 259-283.
description	9.	Nair, Trilokraj P. "Polymorphisms of the IL12B and IL23R Genes Are Associated with Psoriasis." The Journal of investigative dermatology 128.7 (2007): 1653-61.
description	10.	Lowes, Michelle A A. "Pathogenesis and therapy of psoriasis." Nature 445.7130 (2007): 866-873.
description	11.	Estivill, X. "Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis." Nature genetics 41.2 (2008): 211-5.
description	12.	Flytstrom, I. "Methotrexate vs. ciclosporin in psoriasis: effectiveness, quality of life and safety. A randomized controlled trial." British journal of dermatology 158.1 (2008): 116-121.
description	13.	Abtin, A. "Perivascular macrophages mediate neutrophil recruitment during bacterial skin infection." Nature Immunology 15.1 (2013): 45-53.
description	14.	Majmundar, Amar J. "Hypoxia-inducible factors and the response to hypoxic stress." Molecular cell 40.2 (2010): 294-309.
description	15.	Carvalho, L. "Review series on helminths, immune modulation and the hygiene hypothesis: mechanisms underlying helminth modulation of dendritic cell function." Immunology 126.1 (2009): 28-34.
description	16.	Conley, K. "Limits to sustainable muscle performance: interaction between glycolysis and oxidative phosphorylation." The journal of experimental biology 204.18 (2001): 3189-3194.
description	17.	Fraser, L C D. "A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis." Annals of the rheumatic diseases 66.5 (2005): 859-864.
description	18.	Yoon, Hyun S. "A comparison of two cyclosporine dosage regimens for the treatment of severe psoriasis." The Journal of dermatological treatment 18.5 (2007): 286-290.
description	19.	McClure, Stacy L L. "Comparative tolerability of systemic treatments for plaque-type psoriasis." Drug safety 25.13 (2002): 913-27.
description	20.	Sauder, Daniel N N. "Understanding the new clinical landscape for psoriasis: a comparative review of biologics." Journal of cutaneous medicine and surgery 8.4 (2004): 205-12.